TerrAscend Corp. (TSNDF)
(Delayed Data from OTC)
$1.43 USD
-0.02 (-1.38%)
Updated Jul 29, 2024 03:55 PM ET
4-Sell of 5 4
B Value A Growth F Momentum A VGM
TerrAscend Corp. (TSNDF) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$3.51 | $5.11 | $2.50 | 142.07% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for TerrAscend Corp. comes to $3.51. The forecasts range from a low of $2.50 to a high of $5.11. The average price target represents an increase of 142.07% from the last closing price of $1.45.
Analyst Price Targets (5 )
Broker Rating
TerrAscend Corp. currently has an average brokerage recommendation (ABR) of 1.29 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.29 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, six are Strong Buy, representing 85.71% of all recommendations. A month ago, Strong Buy represented 85.71%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/TSNDF.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 7 | 7 |
Buy | 0 | 0 | 0 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.29 | 1.29 | 1.29 | 1.33 | 1.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/23/2024 | Seaport Research Partners | Sonny Randhawa | Strong Buy | Strong Buy |
7/3/2024 | ATB Capital Markets | Frederico Gomes | Strong Buy | Strong Buy |
5/10/2024 | Clarus Securities | Noel Atkinson | Strong Buy | Strong Buy |
3/15/2024 | Needham & Company | Matthew R Mcginley | Hold | Hold |
11/13/2023 | Craig-Hallum | Eric D Lauriers | Strong Buy | Strong Buy |
11/13/2023 | Canaccord Genuity | Matt Bottomley | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.29 |
ABR (Last week) | 1.29 |
# of Recs in ABR | 7 |
Average Target Price | $3.51 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 93 of 252 |
Current Quarter EPS Est: | -0.02 |